LexisNexis® Legal Newsroom
Pennsylvania Jury Finds Prempro Did Not Cause Women's Breast Cancers

PHILADELPHIA - (Mealey's) A Pennsylvania Common Pleas Court jury on Aug. 18 decided that two women's use of Wyeth's Prempro did not cause them to develop breast cancer and that the maker of the hormone replacement therapy should not be required to pay them damages for their illnesses ( Sharon...

Judge Denies Quigley Company's Plan Of Reorganization

NEW YORK - (Mealey's) Finding that Pfizer Inc. manipulated creditor votes in seeking support for a plan of reorganization for its wholly owned subsidiary Quigley Co. Inc., a New York bankruptcy judge on Sept. 8 denied Quigley's plan of reorganization to resolve its asbestos liabilities ( In re...

Pfizer Stock Sold, Roberts To Hear Company's Cases

WASHINGTON, D.C. - (AP) Chief Justice John Roberts has sold his shares of Pfizer Inc., a move that allows him to participate in two pending Supreme Court cases involving the pharmaceutical maker. Federal law requires judges to sit out cases if they own even a single share of stock. . . . Full version...

High Court Hears Case About Vaccine Side Effects

WASHINGTON, D.C. - (AP) The Supreme Court is trying to sort out whether drug companies can be sued for claims of serious side effects from childhood vaccines without driving vaccine makers from the market and risking a public health crisis. Full version available to lexis.com subscribers .

Wyeth Wins 4th Prempro MDL Bellwether Trial

JONESBORO, Ark. - (Mealey's) An Arkansas federal jury on Oct. 19 said a plaintiff did not prove that Wyeth inadequately warned her and her doctor that the hormone replacement therapy drug Prempro could cause breast cancer ( In re: Prempro Products Liability Litigation , MDL Docket No. 1507, No. 03...

2nd Circuit Sends N.J. Whistle-Blower Claims Of Ex-Pfizer Executive Back For Reconsideration

NEW YORK -- (Mealey's) A Second Circuit U.S. Court of Appeals panel on Nov. 17 affirmed summary judgment on federal False Claims Act (FCA) termination claims by former Pfizer executive Peter Rost but reversed judgment as to his claims under New Jersey's whistle-blower protection laws ( Peter...

Citing Liver Damage, Pfizer Withdraws Thelin

NEW YORK - (AP) Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage . Thelin is sold in the European Union, Canada, and Australia as an oral treatment for severe pulmonary arterial hypertension...

Neurontin MDL Judge Grants Summary Judgment Against All But 2 Class Plaintiffs

BOSTON - (Mealey's) The Massachusetts federal judge overseeing the Neurontin multidistrict litigation on Dec. 10 granted summary judgment against all but two class action plaintiffs after finding no direct evidence that Pfizer Inc.'s off-label marketing influenced prescribing physicians ( In...

Parents Lose Supreme Court Appeal In Vaccine Case

WASHINGTON, D.C. - (AP) The Supreme Court closed the courthouse door Tuesday to parents who want to sue drug makers over claims that their children developed autism and other serious health problems from vaccines. The ruling was a stinging defeat for families dissatisfied with how they fared before a...

Lawsuit: Wyeth Had Illegal Patents On Effexor

JACKSON, Miss. - (AP) A federal lawsuit filed this week in Mississippi claims a major pharmaceutical company made millions of dollars by misrepresenting clinical data and using sham litigation to maintain a monopoly over a drug used to treat depression and anxiety. Uniondale Chemists Inc., a retail pharmacy...

Go-It-Alone Whistle-Blowers Force $14.5M Pfizer Settlement For Off-Label Promotion

BOSTON - (Mealey's) Two whistle-blowers who went it alone in prosecuting a False Claims Act lawsuit against Pfizer Inc. in a Massachusetts federal court have forced a $14.5 million settlement for the off-label marketing of Detrol, according to announcements by the plaintiffs on Oct. 20 and a federal...

Duane Morris Alert: Big Win For Drug Companies Under The New Jersey Product Liability Act

On September 29, 2011, in Bailey v. Wyeth, et al. , a New Jersey appellate court affirmed summary judgment in favor of two Pfizer subsidiaries and Wyeth, Inc., dismissing claims for violations of New Jersey's Product Liability Act (PLA). The claims arose from breast cancer injuries allegedly sustained...

Pennsylvania Jury Awards $72.6 Million To 3 Women In HRT Breast Cancer Case

PHILADELPHIA - (Mealey's) A Pennsylvania state court jury on Dec. 6 awarded $72.6 million to three women who say they developed breast cancer after taking hormone replacement therapy (HRT) drugs made by subsidiaries of Pfizer Inc. ( Susan Elfont, et al. v. Wyeth, et al. , No. 040700924, Pa. Comm...

Asbestos Claims Against Quigley Parent Pfizer Allowed By 2nd Circuit

NEW YORK - (Mealey's) Personal injury suits seeking to hold Pfizer Inc. liable for asbestos-containing products manufactured by bankrupt subsidiary Quigley Co. Inc. under an "apparent manufacturer" theory of liability are not barred by an injunction issued in Quigley's Chapter 11 case...

Zoloft Birth Defects MDL Created, Assigned To Eastern District Of Pennsylvania

WASHINGTON, D.C. - (Mealey's) More than 92 federal lawsuits alleging birth defects caused by the antidepressant Zoloft and its generic version sertraline were centralized April 17 before Judge Cynthia M. Rufe in the U.S. District Court for the Eastern District of Pennsylvania by the Judicial Panel...

$4 Million In Compensatory Damages Awarded By Connecticut Jury In Prempro Breast Cancer Trial

NEW HAVEN, Conn. - (Mealey's) A Connecticut federal jury on April 18 awarded a plaintiff and her husband $4 million in compensatory damages after finding that the hormone replacement therapy drug Prempro caused the plaintiff's breast cancer ( Margaret B. Fraser, et al. v. Wyeth, Inc., et al....

Connecticut Federal Jury Finds Warning Adequate In Prempro Wrongful Death Suit

BRIDGEPORT, Conn. - (Mealey's) Wyeth is not liable for the breast cancer death of a woman who took the company's hormone therapy drugs Premarin and Prempro, a Connecticut federal jury said May 30, finding that the drugs' labeling contained adequate warning of the drugs' health risks ...

Wisconsin Supreme Court Affirms $13.5 Million Drug Pricing Verdict Against Pharmacia Corp.

MADISON, Wis. - (Mealey's) The Wisconsin Supreme Court on June 22 affirmed a $13.5 million verdict and judgment against Pharmacia Corp. for reporting inflated drug prices and causing the state Medicaid program to overpay, an appeal that stayed the state's cases against 25 other drug company defendants...

Divided 8th Circuit Panel Readmits Plaintiff Expert On Short-Term Prempro Risk

ST. LOUIS - (Mealey's) In a 2-1 ruling July 26, the Eighth Circuit U.S. Court of Appeals reversed summary judgment in two Prempro bellwether cases that involve the risk of breast cancer in women who took the hormone replacement therapy drug for less than three years ( Pamela Kuhn v. Wyeth, Inc.,...

Pfizer Faces Asbestos Actions After Supreme Court Declines To Hear Case

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 24 denied a bid for certiorari by Pfizer Inc. of a ruling removing the protection for Pfizer of a bankruptcy injunction barring asbestos personal injury claims entered in the case of a defunct Pfizer subsidiary ( Pfizer Inc. v. Law Offices...

Conn. Federal Judge Awards $1.7 Million In Punitive Damages In Prempro Breast Cancer Case

NEW HAVEN, Conn. — (Mealey’s) Applying Connecticut law governing punitive damages in product liability actions, a Connecticut federal judge on Aug. 5 awarded $1,769,932 to a woman and her husband, who in April 2012 were awarded $4 million in compensatory damages by a jury ( Margaret B. Fraser...

Pa. High Court Reconsiders, Won’t Disturb $8.6M Prempro Punitive Damages Award

PHILADELPHIA — (Mealey’s) The Pennsylvania Supreme Court on Dec. 16 let stand an $8.6 million punitive damages verdict in a Prempro hormone replacement therapy case after dismissing the appeal as improvidently granted ( Mary Daniel, et al. v. Wyeth Pharmaceuticals, Inc., et al. , Nos. 63...

Pa. Supreme Court Says Drug Companies Can Be Sued For Marketing Dangerous Drugs

PHILADELPHIA — (Mealey’s) Pennsylvania law allows drug companies to be sued if they fail to stop marketing drugs known to be unreasonably harmful, and the manufacturers are not immune from being sued for damages for lack of due care, the Pennsylvania Supreme Court ruled Jan. 22 in an eight...

Pfizer To Pay $325M To Settle Neurontin 3rd-Party Payer, Antitrust Class Action

BOSTON — (Mealey’s) Pfizer Inc. has agreed to a $325 million class settlement of claims by third-party payers that allege that the off-label promotion of the epilepsy drug Neurontin violated the Racketeer Influenced and Corrupt Organizations Act and that the drug maker’s efforts to...

Defense Verdict Returned In Purported 1st Zoloft Birth Defect Trial

ST. LOUIS — (Mealey’s) A Missouri state court jury on April 17 returned a defense verdict in a Zoloft birth defect trial said by the parties to be the first trial of its kind in the nation ( Kristyn Pesante, et al. v. Pfizer, Inc. , No. 122-CCO-2441-01, Mo. Cir., St. Louis City.). Kristyn...